Amplify Treatments, Testing and Advancements ETF (GERM) News Today $19.16 0.00 (0.00%) As of 04/25/2025 Add Compare Share Share Headlines Stock AnalysisChartHoldingsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Amplia Therapeutics Advances Cancer Drug TrialOctober 30, 2024 | markets.businessinsider.comMpox Variant Sparks Global Concern As Europe, China Ramp Up ScreeningAugust 19, 2024 | benzinga.comAmplify ETFs to Liquidate Three ETFsAugust 15, 2024 | finance.yahoo.comTHNR Amplify Weight Loss Drug & Treatment ETFAugust 1, 2024 | seekingalpha.comETFMG Treatments Testing and Advancements ETFFebruary 11, 2024 | thestreet.comETFMG Treatments, Testing and Advancements ETF declares $0.0522 dividendDecember 28, 2023 | msn.comGERM ETFMG Treatments, Testing and Advancements ETFAugust 25, 2023 | seekingalpha.comETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0600June 23, 2023 | msn.comCutting-edge advances in cancer treatment are underway. Here are 3 that could change lives.April 25, 2023 | usatoday.comJP Morgan Maintains Moderna (MRNA) Neutral RecommendationApril 11, 2023 | msn.comLactose Intolerance Treatment Market Growth by 2031March 24, 2023 | marketwatch.comLatest "Blood Culture Test Market" Insights, Trends & Future Development Status Recorded During 2023-2028March 8, 2023 | marketwatch.comRising Lighting Testing, Inspection and Certification (TIC) Market 2023: Advancements in Near Future and Regional Growth by 2028February 21, 2023 | marketwatch.comPhage Therapy Market is Exhibit a CAGR of 17.6% By Product Type, Application, Key Players and Forecast to 2027 | Report [125 Pages]September 21, 2022 | marketwatch.comElectrophysiological Medical Equipment Market 2021 Huge Demand, Growth Opportunities and Expansion by 2028August 25, 2022 | marketwatch.comEnteric Disease Testing Devices Market Research Report Analysis by Competitors, Sales, Revenue, and Market Size 2022 To 2028.July 14, 2022 | marketwatch.comGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market 2022 Company Challenges, Latest Advancements, Growth Prediction, and Forecast by 2028July 6, 2022 | marketwatch.comGlobal Enteric Disease Testing Market Size is Projected to Reach USD 2.45 billion by 2026July 5, 2022 | benzinga.comargenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in EuropeJune 24, 2022 | finance.yahoo.comGenetic Testing Market is projected to reach USD 36.11 Billion by 2030, growing at a CAGR of 10%: Straits ResearchJune 16, 2022 | finance.yahoo.comGene Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)June 9, 2022 | finance.yahoo.comGlobal ADME-Toxicology Testing Market to Reach US$11.1 Billion by the Year 2026May 24, 2022 | finance.yahoo.comDon’t expect vaccine makers’ shares to jump despite ongoing demand for boosters, treatmentsFebruary 16, 2022 | theglobeandmail.comHealthcare Emerges as Best Sector of Last Week: 5 Top ETFsDecember 20, 2021 | nasdaq.comModerna ETFs to Rally on Positive COVID-19 Booster Shot NewsNovember 22, 2021 | msn.comHow to invest in the future of vaccinesSeptember 28, 2021 | afr.comExpert reveals top pandemic ETF play – up 58% in 12 monthsSeptember 22, 2021 | msn.comSogoTrade ReviewSeptember 2, 2021 | investopedia.com5 Must-Watch ETF Charts of Q2 EarningsAugust 27, 2021 | nasdaq.com Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter. Email Address GERM Media Mentions By Week GERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERM News Sentiment▼0.001.17▲Average News Sentiment GERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERM Articles This Week▼00▲GERM Articles Average Week Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SPAC and New Issue ETF News Grayscale Future of Finance ETF News AdvisorShares MSOX 2X Daily ETF News NYLI Healthy Hearts ETF News Janus Henderson US Sustainable Equity ETF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:GERM) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Treatments, Testing and Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
